NCT01232322
- Conditions
- Asthma, Bronchial Asthma, Bronchial Diseases, +7 more
- Locations
-
Not specified
Clinical trial condition
Lung Diseases, Obstructive
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
7,951 public trials
734 recruiting studies
Lung Diseases, Obstructive trial results
Completed
Effects of an Air Purifying Device (PureNight) on Sleep Quality in Obstructive Lung Disease
NCT01772342
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +13 more
- Locations
-
Not specified
NCT00214383
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified
NCT00982891
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Horizon Health Network Saint John, New Brunswick, Canada
- Capital District Health Authority Halifax, Nova Scotia, Canada
- Royal University Hospital Saskatoon, Saskatchewan, Canada
NCT00557466
- Conditions
- COPD, Chronic Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigator site Buenos Aires, Argentina
- Novartis Investigator Site Rosario, Argentina
- Novartis Investigator Site Santillán, Argentina
- Novartis Investigator Site Liège, Belgium
NCT01119937
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigative Site Fukuoka, Japan
- Novartis Investigative Site Iizuka, Fukuoka, Japan
- Novartis Investigative Site Kitakyushu, Fukuoka, Japan
- Novartis Investigative Site Kitakyushu, Fukuoka, Japan
NCT00670930
- Conditions
- Airway Remodeling, Allergic Asthma, Asthma, +11 more
- Locations
-
- Novartis Investigative Site Denver, Colorado, United States
- Novartis Investigative Site St Louis, Missouri, United States
- Novartis Investigative Site Durham, North Carolina, United States
- Novartis Investigative Site Philadelphia, Pennsylvania, United States
NCT00545272
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Novartis Investigator Site Aalst, Belgium
- Novartis Investigator Site Halen, Belgium
- Novartis Investigator Site Oostham, Belgium
- Novartis Investigator site Veurne, Belgium
Completed
SMS Reminder to Assess Adherence
NCT01308476
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- Boehringer Ingelheim Investigational Site 1 Berlin, Germany
- Boehringer Ingelheim Investigational Site 2 Cottbus, Germany
- Boehringer Ingelheim Investigational Site 3 Hamburg, Germany
- Boehringer Ingelheim Investigational Site 4 Koblenz, Germany
NCT00217776
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
Not specified